Cancer & Blood Disorders Research 

It's part of our mission to advance clinical education and research to create sustained improvements in health care outcomes.

The Johns Hopkins All Children’s Hospital Clinical and Translational Research Organization (CTRO) was established to facilitate clinical and translational research development in pediatrics with reach throughout the region, in Baltimore, and beyond.

Our Cancer & Blood Disorders research includes:

  • More than 100 active research studies in hematology-oncology, with phase 1 trials and phase 2 trials that include investigator/initiated studies.
  • A $717,000 National Cancer Institute innovation grant in 2017 to study the use of saliva instead of plasma to monitor for potential chemotherapy toxicity. The study unites with investigators in St. Petersburg and Baltimore working together to advance the field of biorepository science.
  • A coordinating center for the Prospective Multicenter Evaluation of Duration of Therapy for Thrombosis in Children (the Kids-DOTT Trial), a randomized, controlled and blinded phase 3 clinical trial that includes nearly 40 major pediatric centers worldwide.
  • The ability to store samples for future studies. We are home to the only pediatric biorepository in Florida and part of the Johns Hopkins All Children's Molecular Determinants Core.